Novavax, Inc. (NVAX) Reports Q2 Loss of $0.04
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.00 -1.42%
EPS Growth %: -164.5%
Financial Fact:
Revenue: 102K
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -164.5%
Financial Fact:
Revenue: 102K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q2 EPS of ($0.04), versus ($0.07) reported last year. Revenue for the quarter came in at $3 million versus the consensus estimate of $2.74 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
- Laser Photonics Corporation (LASE) Reports Q1 Loss of $0.11
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
